top
Search terms
Results 1 - 3 of 3 - ordered by :
Escardio

Doctor Jonathan Emberson, University of Oxford British Heart Foundation Senior Statistician, notes, “Statin therapy had no adverse effect on cancer at any site or in any group of individuals, ...

Date : 20/08/2010
Escardio

Sunday 31 August: The investigational drug alirocumab significantly improved cholesterol levels compared to ezetimibe, when added to regular statin therapy in patients with high cholesterol and ...

Date : 31/08/2014
Escardio

Results of the trial, presented as an ESC Hot Line, suggest rosuvastatin may have an initially more favourable effect on glucose levels compared to atorvastatin, making it a wiser choice especially ...

Date : 31/08/2014